Humana (HUM) Depreciation & Amortization (CF) (2009 - 2026)

Humana (HUM) has reported Depreciation & Amortization (CF) for 18 consecutive years, with $180.0 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Depreciation & Amortization (CF) fell 8.16% year-over-year to $180.0 million; the TTM figure through Jun 2026 stood at $740.0 million (down 12.94% YoY), while the FY2025 annual figure was $773.0 million, down 14.87% from the prior year.
• Depreciation & Amortization (CF) slipped to $180.0 million in Q2 2026 per HUM's latest filing, from $183.0 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $228.0 million in Q2 2024 and bottomed at $180.0 million in Q2 2026.
• Historically, Depreciation & Amortization (CF) has averaged $202.4 million across 5 years, with a median of $198.0 million in 2023.
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) advanced 21.29% — and 2025, when it decreased 17.7%.
• Humana's Depreciation & Amortization (CF) stood at $194.0 million in 2022, then gained by 14.43% to $222.0 million in 2023, then increased by 1.8% to $226.0 million in 2024, then slipped by 17.7% to $186.0 million in 2025, then dropped by 3.23% to $180.0 million in 2026.
• Business Quant data shows HUM's Depreciation & Amortization (CF) at $180.0 million in Q2 2026, $183.0 million in Q1 2026, and $186.0 million in Q4 2025.